Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study). J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 20];7(6):s262. Available from: https://skin.dermsquared.com/skin/article/view/2345